Sa
fet
y
43
Although the existing scientific
data do not justify FDA
regulatory actions, the FDA has
urged the wireless phone
industry to take a number of
steps, including the following:
●
Support needed research into
possible biological effects of
RF of the type emitted by
wireless phones;
●
Design wireless phones in a
way that minimizes any RF
exposure to the user that is
not necessary for device
function; and
●
Cooperate in providing users
of wireless phones with the
best possible information on
possible effects of wireless
phone use on human health.
The FDA belongs to an
interagency working group of the
federal agencies that have
responsibility for different
aspects of RF safety to ensure
coordinated efforts at the federal
level. The following agencies
belong to this working group:
●
National Institute for
Occupational Safety and
Health
●
Environmental Protection
Agency
●
Occupational Safety and
Health Administration
●
National Telecommunications
and Information
Administration
The National Institutes of Health
participates in some interagency
working group activities, as well.
The FDA shares regulatory
responsibilities for wireless
phones with the Federal
Communications Commission
(FCC). All phones that are sold
in the United States must comply
